search
Back to results

Prevention of Type 2 Diabetes and Gestational Diabetes Among Women in Kisantu, Democratic Republic of Congo (KIS-Antwerp)

Primary Purpose

Diabetes Mellitus, Type 2, Gestational Diabetes

Status
Active
Phase
Not Applicable
Locations
Congo, The Democratic Republic of the
Study Type
Interventional
Intervention
Educational and motivational strategy
Sponsored by
Institute of Tropical Medicine, Belgium
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Diabetes Mellitus, Type 2 focused on measuring Prevention, Type 2 diabetes, Gestational diabetes, Women of reproductive age, Healthy lifestyle, Democratic Republic of the Congo

Eligibility Criteria

18 Years - 49 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Non-pregnant or (first trimester) pregnant women
  • Women of reproductive age (18-49 years old)
  • Without a previous diagnosis of type 1 diabetes or T2DM (confirmed by a random glucose test)

Exclusion Criteria:

  • Pregnant women with active gestational diabetes
  • Adult males, and children and adolescents <18 years old of both sexes
  • Pre-existent severe chronic conditions (e.g. chronic liver or kidney disease, chronic obstructive pulmonary disease)
  • Living outside of the surrounding catchment areas of the 6 healthcare centers.
  • Women internationally displaced, without a permanent home or identified physical address.
  • Women planning to move elsewhere in the following 2 years
  • Women that do not provide a written Informed Consent.

Sites / Locations

  • KAVWAYA
  • KINKOKA
  • MADIMBA
  • NGEBA
  • NKANDU 1
  • Kintanu Etat

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Intervention group (Educational and motivational strategy)

Comparison group (Basic educational strategy)

Arm Description

The intervention group will be provided with a multi-component intervention entailing the following components distributed over the 24-months study: 4 individualized education sessions at the household, 4 group activities (2 group education sessions and 2 physical activity sessions) at the healthcare center, and 4 focus groups at the healthcare center as well. The motivational components of goal setting and the use of a pedometer will be incorporated in the individualized education sessions. Moreover, community activities will be incorporated in the second year of the study after exploring whether the activities are feasible and acceptable by the community. The topics covered by the intervention are healthy diet, physical activity, weight control strategies and knowledge and awareness of T2DM and GDM. Additionally, at baseline participants will be provided with a healthy lifestyle brochure with general recommendations.

The comparison group will be limited to receive the healthy lifestyle brochure with general recommendations at baseline only.

Outcomes

Primary Outcome Measures

Change from baseline in the adherence to a healthy lifestyle score at 24 months
The adherence to a healthy lifestyle will be measured by using a validated questionnaire for weight control in lifestyle-related diseases that compromise 14 questions, 12 regarding diet and 2 related to physical activity. Each question has 5 multiple choice answers (A, B, C, D, E). This questionnaire provides a final score ranging between 14-65 points. A lower score indicates poor adherence to a healthy lifestyle, while a high score indicates good adherence.
Change from baseline in the adherence to a healthy lifestyle score at 12 months
The adherence to a healthy lifestyle will be measured by using a validated questionnaire for weight control in lifestyle-related diseases that compromise 14 questions, 12 regarding diet and 2 related to physical activity. Each question has 5 multiple choice answers (A, B, C, D, E). This questionnaire provides a final score ranging between 14-65 points. A lower score indicates poor adherence to a healthy lifestyle, while a high score indicates good adherence.

Secondary Outcome Measures

Change from baseline in the minimum diet diversity of women (MDD-W) questionnaire at 24 months
The MDD-W dichotomous questionnaire developed by the Food and Agriculture Organization of the United Nations (FAO) will be used to measure women's diet diversity.
Change from baseline in the minimum diet diversity of women (MDD-W) questionnaire at 12 months
The MDD-W dichotomous questionnaire developed by the Food and Agriculture Organization of the United Nations (FAO) will be used to measure women's diet diversity.
Change from baseline in the International Physical Activity Questionnaire at 24 months
The International Physical activity Questionnaire (IPAQ) short Form will be used to assess the level of physical activity of the participants.
Change from baseline in the International Physical Activity Questionnaire at 12 months
The International Physical activity Questionnaire (IPAQ) short Form will be used to assess the level of physical activity of the participants.
Change from baseline in weight at 24 months
Weight will be measured in kg and by using a digital weight scale. The WHO STEPwise guideline will be followed for this measurement.
Change from baseline in weight at 12 months
Weight will be measured in kg and by using a digital weight scale. The WHO STEPwise guideline will be followed for this measurement.
Change from baseline in Body mass index (BMI) at 24 months
BMI will be calculated by using the formula BMI= weight in kg/height in meters squared.
Change from baseline in Body mass index (BMI) at 12 months
BMI will be calculated by using the formula BMI= weight in kg/height in meters squared.
Change from baseline in waist circumference at 24 months
Waist circumference will be measured in cm and y using a constant tension tape. The WHO STEPwise guideline will be followed for this measurement.
Change from baseline in waist circumference at 12 months
Waist circumference will be measured in cm and y using a constant tension tape. The WHO STEPwise guideline will be followed for this measurement.
Change from baseline in glycemia at 24 months
Glycemia will be measured in mg/dL by using by pricking the fingertip with a lancet and glucometer. The WHO STEPwise guideline will be followed for this measurement.
Change from baseline in glycemia at 12 months
Glycemia will be measured in mg/dL by using by pricking the fingertip with a lancet and glucometer. The WHO STEPwise guideline will be followed for this measurement.
Change from baseline in systolic and diastolic blood pressure at 24 months
Systolic and diastolic blood pressure will me measured in mm Hg and by using an OMRON. The WHO STEPwise guideline will be followed for this measurement.
Change from baseline in systolic and diastolic blood pressure at 12 months
Systolic and diastolic blood pressure will me measured in mm Hg and by using an OMRON. The WHO STEPwise guideline will be followed for this measurement.

Full Information

First Posted
August 19, 2021
Last Updated
February 28, 2023
Sponsor
Institute of Tropical Medicine, Belgium
Collaborators
Memisa, Belgium
search

1. Study Identification

Unique Protocol Identification Number
NCT05039307
Brief Title
Prevention of Type 2 Diabetes and Gestational Diabetes Among Women in Kisantu, Democratic Republic of Congo
Acronym
KIS-Antwerp
Official Title
Prevention of Type 2 Diabetes and Gestational Diabetes Among Women of Reproductive Age in Kisantu, Democratic Republic of Congo
Study Type
Interventional

2. Study Status

Record Verification Date
February 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
October 4, 2021 (Actual)
Primary Completion Date
October 31, 2023 (Anticipated)
Study Completion Date
October 31, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Institute of Tropical Medicine, Belgium
Collaborators
Memisa, Belgium

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This study aims to develop and implement a long-term program focused on the prevention of type 2 diabetes Mellitus (T2DM) and gestational diabetes mellitus (GDM) in women of reproductive age through lifestyle modification. This is a cluster-randomized trial whereby 6 health centers across Kisantu, Democratic Republic of Congo (DRC) will be randomized to an intervention group (3 health centers) or a comparison group (3 health centers). The intervention group will be provided with a preventive program based on educational + motivational strategies when the comparison group will be limited to an educational strategy only. This study will last 24 months and is limited to women of reproductive age (18-49 years), pregnant and non-pregnant. Evaluation of this research will use mixed longitudinal analyses for healthy lifestyle adherence, anthropometric and clinical indicators, diet quality, and physical activity. Expected results of this study for women of reproductive age include the prevention of T2DM and GDM through the acquisition of healthy lifestyle behavior, reaching and maintaining an optimal weight, blood pressure and glycemia, and adhere to the weight gain recommendations during pregnancy. Other expected achievements encompass improvements in the usability of data capturing systems, expand knowledge among health care providers on effective strategies for T2DM and GDM prevention and improve the technique and precision of measurements concerning health visits among health care providers, among others.
Detailed Description
Background: As the obesity epidemic continues to rise, it is expected that rates of T2DM and GDM will be also increasing among women in Sub-Saharan Africa (SSA). Women of reproductive age are a particularly vulnerable group, and there is a need for preventive programs addressing the incidence of obesity, T2DM, and GDM. Objective: This study aims to develop, implement, and evaluate a long-term program (KIS-Antwerp) focused on the prevention of T2DM and GDM in women through a healthy lifestyle promotion. Methods: The study will take place in 6 healthcare centers across Kisantu, DRC, and will be limited to women of reproductive age (18-49 years) irrespectively of pregnancy status. KIS-Antwerp will be implemented and evaluated using a matched cluster randomized controlled trial where the 6 healthcare will be randomized into an intervention group and a comparison group. The duration of the present study is 24 months. A total of 144 participants per arm is necessary to detect a 12% change in the primary outcome with a level of significance of 0.05, power >80%, and considering a 20% loss of follow-up. The intervention group will be provided with a preventive intervention program based on educational + motivational strategies including the following intervention program components: Individualized education, group education, physical activity sessions, setting goals, and usage of a pedometer. The comparison group will be limited to a basic educational strategy only (basic individual education). Participants will be followed up for 24 months and measurements will be assessed every 6-months period. Statistical methods: Demographic characteristics will be reported as measures of central tendency for continuous outcomes and frequency distribution and percentages for binary/categorical data. Consequently, demographic data will be explored for differences at baseline by comparing and testing means. After the termination of the study, the primary and secondary outcomes will be evaluated for normality by the Kolmogorov-Simonov test and visual inspection of histograms. For the primary ordinal outcome, the impact of the intervention program between baseline and follow up of the 2 groups (intervention and comparison group) will be assessed by using linear mixed models for repeated measurements. Safety: This study imposes a low risk for the participants as the intervention program compromises a lifestyle modification through education and motivational strategies and the measurements to be taken are non-invasive, with the exception of blood glucose assessment by blood sampling using a finger prick. For this measurement, guidelines with all the necessary steps and equipment will be followed.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes Mellitus, Type 2, Gestational Diabetes
Keywords
Prevention, Type 2 diabetes, Gestational diabetes, Women of reproductive age, Healthy lifestyle, Democratic Republic of the Congo

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
A cluster randomized controlled trial (cRCT) with a hierarchical design will be conducted whereby 2 groups of 3 healthcare centers (in total 6 healthcare centers) will be randomized to an intervention group or comparison group.
Masking
None (Open Label)
Masking Description
Masking is not possible due to the nature of this research.
Allocation
Randomized
Enrollment
288 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Intervention group (Educational and motivational strategy)
Arm Type
Experimental
Arm Description
The intervention group will be provided with a multi-component intervention entailing the following components distributed over the 24-months study: 4 individualized education sessions at the household, 4 group activities (2 group education sessions and 2 physical activity sessions) at the healthcare center, and 4 focus groups at the healthcare center as well. The motivational components of goal setting and the use of a pedometer will be incorporated in the individualized education sessions. Moreover, community activities will be incorporated in the second year of the study after exploring whether the activities are feasible and acceptable by the community. The topics covered by the intervention are healthy diet, physical activity, weight control strategies and knowledge and awareness of T2DM and GDM. Additionally, at baseline participants will be provided with a healthy lifestyle brochure with general recommendations.
Arm Title
Comparison group (Basic educational strategy)
Arm Type
No Intervention
Arm Description
The comparison group will be limited to receive the healthy lifestyle brochure with general recommendations at baseline only.
Intervention Type
Behavioral
Intervention Name(s)
Educational and motivational strategy
Intervention Description
The intervention will focus on the following topics A) Healthy diet: food pyramid, a healthy plate distribution, type of carbohydrates and fats, healthy cooking techniques and healthy oils. B) Physical activity: definition, types of physical activity, advantages and benefits, examples, active physical activity sessions. C) Weight control: strategies, benefits and healthy weight gain during pregnancy. D) Knowledge and awareness of T2DM and GDM: definition, prevention, management and complications. These topics will be delivered through individualized education, group sessions and focus groups. Participants will be provided with printed material at baseline and also during the individual education sessions at the household containing a brief summary of the topics covered. The motivational components of goal setting and the use of a pedometer will be incorporated explained during the individual education sessions. The intervention will be primarily delivered by trained peer educators.
Primary Outcome Measure Information:
Title
Change from baseline in the adherence to a healthy lifestyle score at 24 months
Description
The adherence to a healthy lifestyle will be measured by using a validated questionnaire for weight control in lifestyle-related diseases that compromise 14 questions, 12 regarding diet and 2 related to physical activity. Each question has 5 multiple choice answers (A, B, C, D, E). This questionnaire provides a final score ranging between 14-65 points. A lower score indicates poor adherence to a healthy lifestyle, while a high score indicates good adherence.
Time Frame
Baseline and 24 months
Title
Change from baseline in the adherence to a healthy lifestyle score at 12 months
Description
The adherence to a healthy lifestyle will be measured by using a validated questionnaire for weight control in lifestyle-related diseases that compromise 14 questions, 12 regarding diet and 2 related to physical activity. Each question has 5 multiple choice answers (A, B, C, D, E). This questionnaire provides a final score ranging between 14-65 points. A lower score indicates poor adherence to a healthy lifestyle, while a high score indicates good adherence.
Time Frame
Baseline and 12 months
Secondary Outcome Measure Information:
Title
Change from baseline in the minimum diet diversity of women (MDD-W) questionnaire at 24 months
Description
The MDD-W dichotomous questionnaire developed by the Food and Agriculture Organization of the United Nations (FAO) will be used to measure women's diet diversity.
Time Frame
Baseline and 24 months
Title
Change from baseline in the minimum diet diversity of women (MDD-W) questionnaire at 12 months
Description
The MDD-W dichotomous questionnaire developed by the Food and Agriculture Organization of the United Nations (FAO) will be used to measure women's diet diversity.
Time Frame
Baseline and 12 months
Title
Change from baseline in the International Physical Activity Questionnaire at 24 months
Description
The International Physical activity Questionnaire (IPAQ) short Form will be used to assess the level of physical activity of the participants.
Time Frame
Baseline and 24 months
Title
Change from baseline in the International Physical Activity Questionnaire at 12 months
Description
The International Physical activity Questionnaire (IPAQ) short Form will be used to assess the level of physical activity of the participants.
Time Frame
Baseline and 12 months
Title
Change from baseline in weight at 24 months
Description
Weight will be measured in kg and by using a digital weight scale. The WHO STEPwise guideline will be followed for this measurement.
Time Frame
Baseline and 24 months
Title
Change from baseline in weight at 12 months
Description
Weight will be measured in kg and by using a digital weight scale. The WHO STEPwise guideline will be followed for this measurement.
Time Frame
Baseline and 12 months
Title
Change from baseline in Body mass index (BMI) at 24 months
Description
BMI will be calculated by using the formula BMI= weight in kg/height in meters squared.
Time Frame
Baseline and 24 months
Title
Change from baseline in Body mass index (BMI) at 12 months
Description
BMI will be calculated by using the formula BMI= weight in kg/height in meters squared.
Time Frame
Baseline and 12 months
Title
Change from baseline in waist circumference at 24 months
Description
Waist circumference will be measured in cm and y using a constant tension tape. The WHO STEPwise guideline will be followed for this measurement.
Time Frame
Baseline and 24 months
Title
Change from baseline in waist circumference at 12 months
Description
Waist circumference will be measured in cm and y using a constant tension tape. The WHO STEPwise guideline will be followed for this measurement.
Time Frame
Baseline and 12 months
Title
Change from baseline in glycemia at 24 months
Description
Glycemia will be measured in mg/dL by using by pricking the fingertip with a lancet and glucometer. The WHO STEPwise guideline will be followed for this measurement.
Time Frame
Baseline and 24 months
Title
Change from baseline in glycemia at 12 months
Description
Glycemia will be measured in mg/dL by using by pricking the fingertip with a lancet and glucometer. The WHO STEPwise guideline will be followed for this measurement.
Time Frame
Baseline and 12 months
Title
Change from baseline in systolic and diastolic blood pressure at 24 months
Description
Systolic and diastolic blood pressure will me measured in mm Hg and by using an OMRON. The WHO STEPwise guideline will be followed for this measurement.
Time Frame
Baseline and 24 months
Title
Change from baseline in systolic and diastolic blood pressure at 12 months
Description
Systolic and diastolic blood pressure will me measured in mm Hg and by using an OMRON. The WHO STEPwise guideline will be followed for this measurement.
Time Frame
Baseline and 12 months

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
49 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Non-pregnant or (first trimester) pregnant women Women of reproductive age (18-49 years old) Without a previous diagnosis of type 1 diabetes or T2DM (confirmed by a random glucose test) Exclusion Criteria: Pregnant women with active gestational diabetes Adult males, and children and adolescents <18 years old of both sexes Pre-existent severe chronic conditions (e.g. chronic liver or kidney disease, chronic obstructive pulmonary disease) Living outside of the surrounding catchment areas of the 6 healthcare centers. Women internationally displaced, without a permanent home or identified physical address. Women planning to move elsewhere in the following 2 years Women that do not provide a written Informed Consent.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jean C. Kalobu, MD; MPH
Organizational Affiliation
Memisa
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
José L. Peñalvo, PhD
Organizational Affiliation
Institute of Tropical Medicine
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Diana M. Sagastume, MSc
Organizational Affiliation
Institute of Tropical Medicine
Official's Role
Principal Investigator
Facility Information:
Facility Name
KAVWAYA
City
Kisantu
State/Province
Kongo Central
Country
Congo, The Democratic Republic of the
Facility Name
KINKOKA
City
Kisantu
State/Province
Kongo Central
Country
Congo, The Democratic Republic of the
Facility Name
MADIMBA
City
Kisantu
State/Province
Kongo Central
Country
Congo, The Democratic Republic of the
Facility Name
NGEBA
City
Kisantu
State/Province
Kongo Central
Country
Congo, The Democratic Republic of the
Facility Name
NKANDU 1
City
Kisantu
State/Province
Kongo Central
Country
Congo, The Democratic Republic of the
Facility Name
Kintanu Etat
City
Kisantu
State/Province
Kongo Cnetral
Country
Congo, The Democratic Republic of the

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
36084047
Citation
Sagastume D, Sibongwere DK, Kidima O, Kembo DM, N'keto JM, Dimbelolo JC, Nkakirande DB, Kabundi JCK, Penalvo JL. Improving lifestyle behaviours among women in Kisantu, the Democratic Republic of the Congo: A protocol of a cluster randomised controlled trial. PLoS One. 2022 Sep 9;17(9):e0274517. doi: 10.1371/journal.pone.0274517. eCollection 2022.
Results Reference
derived

Learn more about this trial

Prevention of Type 2 Diabetes and Gestational Diabetes Among Women in Kisantu, Democratic Republic of Congo

We'll reach out to this number within 24 hrs